{"CAPTION FIG1.png": "'Figure 1. a) Molecular design of fluorescent probes for detection of folate receptors. The structures of FolateSiR-1 and FolateSiR-2 are also shown. b) Absorption and emission spectra of 1 um FolateSiR-1 in 100 mm sodium phosphate buffer at pH 7.4, \\\\(\\\\lambda_{\\\\rm in}=652\\\\) nm. c) Absorption and emission spectra of 1 um FolabeSR-2 in 100 mm sodium phosphate buffer at pH 7.4, \\\\(\\\\lambda_{\\\\rm in}=656\\\\) nm.\\n\\n'", "CAPTION FIG2.png": "'Figure 2. a) Bright-field (left) and fluorescence (right) images of KB cells incubated with 5 mm **FolateSIR-1** or **FolateSIR-2** in the presence of absence of 1 mm folic acid and 0.5% DMSO as a cosolvent. White arrows indicate bright dots inside cells; \\\\(\\\\lambda_{m}=650\\\\) nm, \\\\(\\\\lambda_{m}=670\\\\)- 750 nm. Scale bars = 20 mm. b) Bright-field (left) and fluorescence (right) images of OWCAR-3 cells incubated with 5 mm **FolateSIR-1** or **FolateSIR-2** and 0.5% DMSO as a cosolvent. White arrows indicate bright dots inside cells, \\\\(\\\\lambda_{m}=650\\\\) nm, \\\\(\\\\lambda_{m}=670\\\\)- 750 nm. Scale bars = 20 mm.\\n\\n'", "CAPTION FIG3.png": "'Figure 3. a) Schematic of folate receptor (\\\\(-\\\\)Folbp 1) expression in mouse embryo: regions reported to show folate receptor expression are shown in gray. b) Fluorescence image of mouse embryo incubated with 20 um FolateSiR-1. Locations stained with FolateSiR-1 are indicated by white arrowheads. c) Fluorescence image of mouse embryo incubated with 20 um FolateSiR-2.\\n\\n'", "CAPTION FIG4.png": "'Figure 4: a) Fluorescence images at different time points of KB tumor-bearing mouse injected with 100 \\\\(\\\\mu\\\\)m **FolateSR-1** in 100 \\\\(\\\\mu\\\\)L saline containing 1% DMSO as a cosolvent. Fluorescence and white light images were obtained before and 0, 0.5, 1, 2, 3 and 6 h after the probe injection; \\\\(\\\\lambda_{in}=\\\\) 661 (641\u2013681) nm, \\\\(\\\\lambda_{in}=\\\\) 700\u2013800 nm. \\\\(T=\\\\) tumor; \\\\(M=\\\\) muscle. Fluorescence intensity scale: gray scale 0 to 233. b) Time-dependent change of fluorescence intensity in tumor and non-tumor (muscle) areas of three mice, including the mouse in (a). Error bar shows S.E. c) Fluorescence images at different time points of KB tumor-bearing mouse injected with 100 \\\\(\\\\mu\\\\)m **FolateSR-2** in 100 \\\\(\\\\mu\\\\)L saline containing 1% DMSO as a cosolvent. Fluorescence and white light images were obtained before and 0, 0.5, 1, 2, 3 and 6 h after the probe injection; \\\\(\\\\lambda_{in}=\\\\) 661 (641\u2013681) nm, \\\\(\\\\lambda_{out}=\\\\) 700\u2013800 nm. \\\\(T=\\\\) tumor; \\\\(M=\\\\) muscle. Fluorescence intensity scale: gray scale 0 to 233. d) Time-dependent change of fluorescence intensity in tumor and non-tumor (muscle) areas of three mice, including the mouse in (c). Error bar shows S.E.\\n\\n'", "CAPTION FIG5.png": "'Figure 5: a) The ovarian cancer tissue microarray was incubated with 5 um FolateSiR-1 and 2.9 um D4PI (nuclear stain) in phosphate-buffered saline containing 0.05 % Tween 20 (PBST) for 2 h. There, the tissue microarray was washed with PBST three times and the fluorescence image was obtained. The microarray contains 37 tumor tissues and 3 normal tissues. Fluorescence images of the 3 normal tissues and 3 representative tumor tissues are shown, scale bar = 2 mm. b) immunostaining of folate receptors in the tissue microarray. The immunostained 3 normal tissues and 3 tumor tissues correspond to those in (a), scale bar = 2 mm.\\n\\n'", "CAPTION FIGNA.png": "'\\n\\n**Scheme 1**.: Imaging strategy of existing near-infrared fluorescent probes for an vivo fluorescence imaging of whole animals.\\n\\n'", "SUPP CAPTION FIGS1.png": "'\\n\\n**Figure S1.** Immunostaining images of KB cells (a), OVCAR-3 cells (b), and HT1080 cells (c). Cells were fixed with 4% PFA/PBS for 20 min, labeled with human anti-folate binding protein antibody for 1 hr, washed, and labeled with second antibody conjugated with Alexa Fluor(r) 488 for 1 hr. Ex. 488 nm; Em. 500-535 nm. Scale bars: 20 \\\\(\\\\upmu\\\\)m.\\n\\n'", "SUPP CAPTION FIGS10.png": "'\\n\\n**Figure S10.** Components of the frozen human ovary tumor tissue array (Catalog No.: T6235183-5; Lot No.3 B705061).\\n\\n'", "SUPP CAPTION FIGS11.png": "'\\n\\n**Figure S11.** Fluorescence staining of the tissue microarray described in Figure S8 with **FolateSiR-1** (pink) and DAPI (Blue). Scale bar represents 2 mm.\\n\\n'", "SUPP CAPTION FIGS12.png": "'\\n\\n**Figure S12.** Immunostaining of folate receptors in the tissue microarray described in Figure S8. Scale bar represents 2 mm.\\n\\n'", "SUPP CAPTION FIGS13-1.png": "'\\n\\n**Figure S13.** (a) The magnified fluorescence images of C4, B8, C3 and A5 specimens in Figure S11 are shown. Red color indicates the fluorescence of **FolateSiR-1**. All specimens showed the fluorescence signal, though the'", "SUPP CAPTION FIGS13-2.png": "'fluorescence intensities were weak in C3 and A5 specimens. (b) The magnified folate receptor-immunostaining images of C4, B8, C3 and A5 in Figure S12 are shown. All specimens were immunostained, though the sample condition of B8, C3 and A5 were not good. (c) The magnified fluorescence image (left) and the magnified immunostaining image (right) of C4 specimen in (a) and (b) are shown. Arrows indicate the boundary between tumor tissues and non-tumor tissues (vascular tissues and fibrous tissues). The tumor tissues are selectively stained by the fluorescent probe, **FolateSiR-1**.\\n\\n'", "SUPP CAPTION FIGS13.png": "'Figure 10.4(a) The spatial distribution of the spatial\\n\\n'", "SUPP CAPTION FIGS14.png": "'\\n\\n**Figure S14.** Absorption spectra of 1 \\\\(\\\\mu\\\\)M 2-COOH SiR650 in 100 mM sodium phosphate buffer at pH 7.4 with or without 10% fetal bovine serum (FBS).\\n\\n'", "SUPP CAPTION FIGS15.png": "'\\n\\n**Figure S15.** Absorbance spectra of 1 \\\\(\\\\upmu\\\\)M **FolateSiR-1** in phosphate buffered saline (PBS) containing 0.1% DMSO with or without 10% FBS (Biowest, Cat. No.: S1810-500), or in mouse serum (FUJIFILM Wako Pure Chemical Corp., Cat. No.: 146-06551).\\n\\n'", "SUPP CAPTION FIGS2.png": "'\\n\\n**Figure S2.** Fluorescence images of KB cells (FR+) (a) and OVCAR-3 cells (FR-) (b) obtained with a commercially available near-infrared fluorescent probe, **FolateRSense** (PerkinElmer Inc.). White arrows indicate bright dots inside cells. Ex. 650 nm, Em. 670-750 nm. Scale bars: 20 \\\\(\\\\mu\\\\)m.\\n\\n'", "SUPP CAPTION FIGS3-1.png": "'\\n\\n**Figure S3.** (a) Fluorescence images of KB cells (left) and OVCAR-3 cells (right) incubated with fluorophore-labeled folates. Emission: 490 nm (**Fluorescein Folate**, **Alexa488 Folate**), 555 nm (**TAMRA Folate**) and 595 nm (**2-Me DCTM Folate**, **2-COOH DCTM Folate**). Excitation: 510-540 nm (**Fluorescein Folate**, **Alexa488 Folate**), 575-600 nm (**TAMRA Folate**) and 610-650 nm (**2-Me DCTM Folate**, **2-COOH DCTM Folate**). Scale bars: 20 \\\\(\\\\mu\\\\)m. (b) Photophysical properties of fluorophore-labeled folates. \\\\({}^{a}\\\\)Photophysical properties were measured in 0.1 N NaOH aq. with fluorescein in 0.1 N NaOH aq. (\\\\(\\\\Phi_{\\\\text{fl}}\\\\)\\\\(=\\\\) 0.85) as a standard. \\\\({}^{b}\\\\)Photophysical properties were measured in 100 mM sodium phosphate buffer (pH 7.4) with fluorescein in 0.1 N NaOH aq. (\\\\(\\\\Phi_{\\\\text{fl}}\\\\)\\\\(=\\\\)'", "SUPP CAPTION FIGS3-2.png": "'0.85) as a standard. \\\\({}^{c}\\\\) Photophysical properties were measured in 100 mM sodium phosphate buffer (pH 7.4) with Rhodamine B in EtOH (\\\\(\\\\Phi_{\\\\mathrm{fl}}\\\\) = 0.65) as a standard. \\\\({}^{d}\\\\) Photophysical properties were measured in 100 mM sodium phosphate buffer (pH 9.0) with 2-Me TokyoMagenta in 100 mM sodium phosphate buffer (pH 9.0) (\\\\(\\\\Phi_{\\\\mathrm{fl}}\\\\) = 0.42) as a standard.\\n\\n'", "SUPP CAPTION FIGS3.png": "'Figure 30. (a): Photoemission images of 488\\n\\n'", "SUPP CAPTION FIGS4-1.png": "'\\n\\n**Figure S4.** (a) KB cells were incubated with **FolateSiR-1**, then fixed with 4% formaldehyde, and bright-field and fluorescence images were obtained. (b) Fluorescence image of mouse embryo incubated with 10 mM **FolateSiR-1**'", "SUPP CAPTION FIGS4-2.png": "'in DMEM containing 10% rat IC-serum. Then, the mouse embryo was fixed with 4% formaldehyde. Locations stained with **FolateSiR-1** are indicated by white arrowheads. (c) Fluorescence image of mouse embryo incubated with 10 mM **FolateSiR-1** in the presence of 1 mM folic acid, and then fixed with 4% formaldehyde.\\n\\n'", "SUPP CAPTION FIGS4.png": "'\\n\\n**Figure**. **A**: (a) (a) (a) (b) (c) (d) (e) (f) (g) (h) (i) ('", "SUPP CAPTION FIGS5.png": "'\\n\\n**Figure S5.** (a) Fluorescence images of mouse embryos incubated with 10 \\\\(\\\\upmu\\\\)**M****FolateSiR-1** and fixed with 4% formaldehyde. The right images are magnifications of the indicated portions of the left images. The regions stained with **FolateSiR-1** are indicated by white arrowheads. The cells indicated by yellow arrows appear to be dead cells. Scale bars: 50 \\\\(\\\\upmu\\\\)m. (b,c) Bright-field (left) and fluorescence (right) images of mouse embryos fixed with 4% formaldehyde in the absence (b) or presence (c) of 1 mM folic acid. These data indicate that the autofluorescence of the fixed embryos with or without 1 mM folic acid is sufficiently low compared with those in (a). Scale bars: 50 \\\\(\\\\upmu\\\\)m.\\n\\n'", "SUPP CAPTION FIGS6.png": "'and fluorescence images of extracted organs of the mouse in Figure 4a. (b) White-light and fluorescence images of extracted organs of the mouse in Figure 4c.\\n\\n'", "SUPP CAPTION FIGS7.png": "'\\n\\n**Figure S7.**_In vivo_ fluorescence imaging of HT1080 tumor-bearing mice injected with 100 \\\\(\\\\upmu\\\\)M **FolateSiR-1** in 100 \\\\(\\\\upmu\\\\)L saline (n = 3). (a) Time-lapse white-light (top) and fluorescence (bottom) images of a mouse. The images were obtained before the probe injection and 0, 0.5, 1, 2, 3 and 6 h after the probe injection. Ex./Em. = 661/700-800 nm. T: Tumor; M: Muscle. Fluorescence intensity scale: gray scale 0 to 255. (b) The time-dependent fluorescence intensity changes of tumor and non-tumor (muscle) areas of three mice. Error bar shows S.E. (c) White-light (top) and fluorescence (bottom) images of extracted mouse organs.\\n\\n'", "SUPP CAPTION FIGS8.png": "'\\n\\n**Figure S8.**_In vivo_ fluorescence imaging of HT1080 tumor-bearing mice injected with 100 \\\\(\\\\upmu\\\\)M **FolateSiR-2** in 100 \\\\(\\\\upmu\\\\)L saline (n = 3). (a) Time-lapse white-light (top) and fluorescence (bottom) images of a mouse. The images were obtained before the probe injection and 0, 0.5, 1, 2, 3 and 6 h after the probe injection. Ex./Em. = 661/700-800 nm. T: Tumor; M: Muscle. Fluorescence intensity scale: gray scale 0 to 255. (b) The time-dependent fluorescence intensity changes in tumor and non-tumor (muscle) areas of three mice. Error bar shows S.E. (c) White-light (top) and fluorescence (bottom) images of extracted mouse organs.\\n\\n'", "SUPP CAPTION FIGS9.png": "'\\n\\n**Figure S9.**_In vivo_ fluorescence imaging of KB tumor-bearing mice injected with 6 mM folic acid in 100 mL saline, then with 100 mM **FolateSiR-1** in 100 mL saline (n = 3). (a) Time-lapse white-light (top) and fluorescence (bottom) images of a mouse. The images were obtained before the probe injection and 0, 0.5, 1, 2, 3 and 6 h after the probe injection. Ex./Em. = 661/700-800 nm. T: Tumor; M: Muscle. Fluorescence intensity scale: gray scale 0 to 255. (b) The time-dependent fluorescence intensity changes of tumor and non-tumor (muscle) areas of three mice. Error bar shows S.E. (c) White-light (top) and fluorescence (bottom) images of extracted mouse organs.\\n\\n'", "SUPP CAPTION FIGSCHEMES1.png": "'\\n\\n**Scheme S1. Synthesis of 2,5-dicCOOH** SIR650'", "SUPP CAPTION FIGSCHEMES10.png": "'\\n\\n**Scheme S10. Synthesis of TAMIRA**'", "SUPP CAPTION FIGSCHEMES11.png": "'\\n\\n**Scheme S11.** Synthesis of 2-COOH SiR650'", "SUPP CAPTION FIGSCHEMES2.png": "'\\n\\n**Scheme S2.** Synthesis of **2-Me-5-COOH** **SiR650**'", "SUPP CAPTION FIGSCHEMES3.png": "'\\n\\n**Scheme S3. Synthesis of Folate-peptide.**'", "SUPP CAPTION FIGSCHEMES4.png": "'\\n\\n**Scheme S4. Synthesis of FoliateSIR-1**'", "SUPP CAPTION FIGSCHEMES5.png": "'\\n\\n**Scheme S5.** Synthesis of FoliateSilk-2'", "SUPP CAPTION FIGSCHEMES6.png": "'\\n\\n**Scheme S6. Synthesis of 2-Me DCTM**'", "SUPP CAPTION FIGSCHEMES7.png": "'\\n\\n**Scheme S7. Synthesis of 2-COOH DCTM folate**'", "SUPP CAPTION FIGSCHEMES8.png": "'\\n\\n**Scheme S8.** Synthesis of Fluorescence foldate'", "SUPP CAPTION FIGSCHEMES9.png": "'\\n\\n**Scheme S9. Synthesis of Alexa488**'", "SUPP CAPTION NA.png": "\"Synthesis of 1,1'-(4-bromo-1,3-phenylene)bis(4-methyl-2,6,7-trioxabicyclo[2.2.2]octane)\""}